(SCSC) ScanSource - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8060371072
Mobility, Barcode, Pos, Payments, Security
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 33.6% |
| Value at Risk 5%th | 49.3% |
| Relative Tail Risk | -10.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.57 |
| Alpha | -33.11 |
| CAGR/Max DD | 0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.595 |
| Beta | 0.985 |
| Beta Downside | 0.834 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.21% |
| Mean DD | 13.68% |
| Median DD | 13.42% |
Description: SCSC ScanSource November 30, 2025
ScanSource, Inc. (NASDAQ:SCSC) distributes a broad portfolio of technology products and solutions across the United States and internationally. The company operates two primary segments: Specialty Technology Solutions, which sells mobility, barcode, point-of-sale, payment, physical-security, networking, and communications hardware and software; and Intelisys & Advisory, which provides connectivity, software-defined networking, unified communications, cloud/data-center, security, AI, and IoT services to channel partners serving end-users ranging from small businesses to enterprises.
Key recent metrics indicate the firm generated approximately $2.2 billion in revenue for FY 2023, up roughly 6 % year-over-year, with an operating margin near 5 %. The technology-distribution sector is projected to grow at a 5 % compound annual rate through 2029, driven by sustained enterprise IT spend (≈4 % YoY) and accelerating adoption of IoT, edge-computing, and security solutions-areas where ScanSource’s product mix is expanding.
For a deeper quantitative view, you might explore the ValueRay platform’s analyst toolkit to extend this high-level overview.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (74.5m TTM) > 0 and > 6% of Revenue (6% = 180.3m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -12.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.33% (prev 21.73%; Δ 1.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 90.7m > Net Income 74.5m (YES >=105%, WARN >=100%) |
| Net Debt (-117.1m) to EBITDA (135.2m) ratio: -0.87 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (22.4m) change vs 12m ago -9.09% (target <= -2.0% for YES) |
| Gross Margin 13.79% (prev 12.48%; Δ 1.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 171.5% (prev 176.8%; Δ -5.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.59 (EBITDA TTM 135.2m / Interest Expense TTM 7.82m) >= 6 (WARN >= 3) |
Altman Z'' 6.23
| (A) 0.41 = (Total Current Assets 1.31b - Total Current Liabilities 606.2m) / Total Assets 1.72b |
| (B) 0.60 = Retained Earnings (Balance) 1.02b / Total Assets 1.72b |
| (C) 0.06 = EBIT TTM 106.2m / Avg Total Assets 1.75b |
| (D) 1.14 = Book Value of Equity 914.0m / Total Liabilities 802.9m |
| Total Rating: 6.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.75
| 1. Piotroski 5.0pt |
| 2. FCF Yield 10.55% |
| 3. FCF Margin 2.74% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -0.87 |
| 6. ROIC - WACC (= -2.22)% |
| 7. RoE 8.22% |
| 8. Rev. Trend -74.69% |
| 9. EPS Trend -24.85% |
What is the price of SCSC shares?
As of December 14, 2025, the stock is trading at USD 41.92 with a total of 194,547 shares traded.
Over the past week, the price has changed by +2.37%, over one month by +1.09%, over three months by -5.80% and over the past year by -20.24%.
Over the past week, the price has changed by +2.37%, over one month by +1.09%, over three months by -5.80% and over the past year by -20.24%.
Is SCSC a buy, sell or hold?
ScanSource has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy SCSC.
- Strong Buy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SCSC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53 | 26.4% |
| Analysts Target Price | 53 | 26.4% |
| ValueRay Target Price | 42.6 | 1.5% |
SCSC Fundamental Data Overview December 10, 2025
Market Cap USD = 898.6m (898.6m USD * 1.0 USD.USD)
P/E Trailing = 12.725
P/E Forward = 11.4679
P/S = 0.299
P/B = 0.9831
P/EG = 1.1464
Beta = 1.289
Revenue TTM = 3.00b USD
EBIT TTM = 106.2m USD
EBITDA TTM = 135.2m USD
Long Term Debt = 126.0m USD (from longTermDebt, last quarter)
Short Term Debt = 7.87m USD (from shortTermDebt, last quarter)
Debt = 7.87m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -117.1m USD (from netDebt column, last quarter)
Enterprise Value = 781.5m USD (898.6m + Debt 7.87m - CCE 124.9m)
Interest Coverage Ratio = 13.59 (Ebit TTM 106.2m / Interest Expense TTM 7.82m)
FCF Yield = 10.55% (FCF TTM 82.4m / Enterprise Value 781.5m)
FCF Margin = 2.74% (FCF TTM 82.4m / Revenue TTM 3.00b)
Net Margin = 2.48% (Net Income TTM 74.5m / Revenue TTM 3.00b)
Gross Margin = 13.79% ((Revenue TTM 3.00b - Cost of Revenue TTM 2.59b) / Revenue TTM)
Gross Margin QoQ = 14.53% (prev 12.93%)
Tobins Q-Ratio = 0.46 (Enterprise Value 781.5m / Total Assets 1.72b)
Interest Expense / Debt = 24.33% (Interest Expense 1.91m / Debt 7.87m)
Taxrate = 26.37% (7.12m / 27.0m)
NOPAT = 78.2m (EBIT 106.2m * (1 - 26.37%))
Current Ratio = 2.16 (Total Current Assets 1.31b / Total Current Liabilities 606.2m)
Debt / Equity = 0.01 (Debt 7.87m / totalStockholderEquity, last quarter 914.0m)
Debt / EBITDA = -0.87 (Net Debt -117.1m / EBITDA 135.2m)
Debt / FCF = -1.42 (Net Debt -117.1m / FCF TTM 82.4m)
Total Stockholder Equity = 905.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.34% (Net Income 74.5m / Total Assets 1.72b)
RoE = 8.22% (Net Income TTM 74.5m / Total Stockholder Equity 905.7m)
RoCE = 10.30% (EBIT 106.2m / Capital Employed (Equity 905.7m + L.T.Debt 126.0m))
RoIC = 7.50% (NOPAT 78.2m / Invested Capital 1.04b)
WACC = 9.72% (E(898.6m)/V(906.4m) * Re(9.65%) + D(7.87m)/V(906.4m) * Rd(24.33%) * (1-Tc(0.26)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.96%
[DCF Debug] Terminal Value 63.55% ; FCFE base≈175.2m ; Y1≈115.0m ; Y5≈52.6m
Fair Price DCF = 36.86 (DCF Value 808.7m / Shares Outstanding 21.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -24.85 | EPS CAGR: 1.03% | SUE: 1.46 | # QB: 3
Revenue Correlation: -74.69 | Revenue CAGR: -4.06% | SUE: -1.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.99 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-06-30): EPS=4.23 | Chg30d=+0.155 | Revisions Net=+4 | Growth EPS=+18.5% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=4.73 | Chg30d=+0.011 | Revisions Net=+2 | Growth EPS=+11.8% | Growth Revenue=+4.5%
P/E Trailing = 12.725
P/E Forward = 11.4679
P/S = 0.299
P/B = 0.9831
P/EG = 1.1464
Beta = 1.289
Revenue TTM = 3.00b USD
EBIT TTM = 106.2m USD
EBITDA TTM = 135.2m USD
Long Term Debt = 126.0m USD (from longTermDebt, last quarter)
Short Term Debt = 7.87m USD (from shortTermDebt, last quarter)
Debt = 7.87m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -117.1m USD (from netDebt column, last quarter)
Enterprise Value = 781.5m USD (898.6m + Debt 7.87m - CCE 124.9m)
Interest Coverage Ratio = 13.59 (Ebit TTM 106.2m / Interest Expense TTM 7.82m)
FCF Yield = 10.55% (FCF TTM 82.4m / Enterprise Value 781.5m)
FCF Margin = 2.74% (FCF TTM 82.4m / Revenue TTM 3.00b)
Net Margin = 2.48% (Net Income TTM 74.5m / Revenue TTM 3.00b)
Gross Margin = 13.79% ((Revenue TTM 3.00b - Cost of Revenue TTM 2.59b) / Revenue TTM)
Gross Margin QoQ = 14.53% (prev 12.93%)
Tobins Q-Ratio = 0.46 (Enterprise Value 781.5m / Total Assets 1.72b)
Interest Expense / Debt = 24.33% (Interest Expense 1.91m / Debt 7.87m)
Taxrate = 26.37% (7.12m / 27.0m)
NOPAT = 78.2m (EBIT 106.2m * (1 - 26.37%))
Current Ratio = 2.16 (Total Current Assets 1.31b / Total Current Liabilities 606.2m)
Debt / Equity = 0.01 (Debt 7.87m / totalStockholderEquity, last quarter 914.0m)
Debt / EBITDA = -0.87 (Net Debt -117.1m / EBITDA 135.2m)
Debt / FCF = -1.42 (Net Debt -117.1m / FCF TTM 82.4m)
Total Stockholder Equity = 905.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.34% (Net Income 74.5m / Total Assets 1.72b)
RoE = 8.22% (Net Income TTM 74.5m / Total Stockholder Equity 905.7m)
RoCE = 10.30% (EBIT 106.2m / Capital Employed (Equity 905.7m + L.T.Debt 126.0m))
RoIC = 7.50% (NOPAT 78.2m / Invested Capital 1.04b)
WACC = 9.72% (E(898.6m)/V(906.4m) * Re(9.65%) + D(7.87m)/V(906.4m) * Rd(24.33%) * (1-Tc(0.26)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.96%
[DCF Debug] Terminal Value 63.55% ; FCFE base≈175.2m ; Y1≈115.0m ; Y5≈52.6m
Fair Price DCF = 36.86 (DCF Value 808.7m / Shares Outstanding 21.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -24.85 | EPS CAGR: 1.03% | SUE: 1.46 | # QB: 3
Revenue Correlation: -74.69 | Revenue CAGR: -4.06% | SUE: -1.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.99 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-06-30): EPS=4.23 | Chg30d=+0.155 | Revisions Net=+4 | Growth EPS=+18.5% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=4.73 | Chg30d=+0.011 | Revisions Net=+2 | Growth EPS=+11.8% | Growth Revenue=+4.5%
Additional Sources for SCSC Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle